Martina Meßner

664 total citations
9 papers, 434 citations indexed

About

Martina Meßner is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Martina Meßner has authored 9 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Martina Meßner's work include Atherosclerosis and Cardiovascular Diseases (3 papers), Adenosine and Purinergic Signaling (1 paper) and Click Chemistry and Applications (1 paper). Martina Meßner is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (3 papers), Adenosine and Purinergic Signaling (1 paper) and Click Chemistry and Applications (1 paper). Martina Meßner collaborates with scholars based in Germany, Austria and Denmark. Martina Meßner's co-authors include Sucharit Bhakdi, Mariam Klouche, Bernhard Dorweiler, Jan Torzewski, Michael Torzewski, Helmut E. Gabbert, Sandra Gottschling, Matthias Husmann, Sandip M. Kanse and Andreas E. May and has published in prestigious journals such as Chemical Communications, Scientific Reports and The FASEB Journal.

In The Last Decade

Martina Meßner

9 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina Meßner Germany 8 200 125 97 78 50 9 434
Blandine Maître France 11 302 1.5× 109 0.9× 25 0.3× 59 0.8× 22 0.4× 19 563
BJ Rollins United States 5 255 1.3× 100 0.8× 47 0.5× 48 0.6× 38 0.8× 7 504
Tadashi Onoda Japan 12 129 0.6× 120 1.0× 68 0.7× 42 0.5× 16 0.3× 38 400
Gunnel Östergren‐Lundén Sweden 10 76 0.4× 298 2.4× 58 0.6× 40 0.5× 58 1.2× 12 476
Susanne Aschermann Germany 7 333 1.7× 163 1.3× 26 0.3× 38 0.5× 21 0.4× 9 506
Cam T. Ha United States 15 208 1.0× 247 2.0× 25 0.3× 17 0.2× 104 2.1× 16 644
Keizo Kato Japan 10 79 0.4× 212 1.7× 69 0.7× 46 0.6× 18 0.4× 13 403
Selina McHarg United Kingdom 12 187 0.9× 223 1.8× 26 0.3× 32 0.4× 23 0.5× 18 605
R. Standring United Kingdom 10 87 0.4× 126 1.0× 76 0.8× 35 0.4× 92 1.8× 27 483
Katarzyna Grys United Kingdom 8 724 3.6× 101 0.8× 117 1.2× 35 0.4× 14 0.3× 11 928

Countries citing papers authored by Martina Meßner

Since Specialization
Citations

This map shows the geographic impact of Martina Meßner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Meßner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Meßner more than expected).

Fields of papers citing papers by Martina Meßner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Meßner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Meßner. The network helps show where Martina Meßner may publish in the future.

Co-authorship network of co-authors of Martina Meßner

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Meßner. A scholar is included among the top collaborators of Martina Meßner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Meßner. Martina Meßner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Meßner, Martina, Mathias W. Hackl, Karolina Szczepanowska, et al.. (2021). Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers. Scientific Reports. 11(1). 11185–11185. 6 indexed citations
2.
Meßner, Martina, Sabine Schmitt, Thomas Fröhlich, et al.. (2020). Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma. The FASEB Journal. 34(9). 11860–11882. 10 indexed citations
3.
Lakemeyer, Markus, et al.. (2018). Design and synthesis of tailored human caseinolytic protease P inhibitors. Chemical Communications. 54(70). 9833–9836. 28 indexed citations
4.
Wiesner, Diana, Martina Meßner, Alexander Karabatsiakis, et al.. (2016). Telomere shortening leads to earlier age of onset in ALS mice. Aging. 8(2). 382–393. 29 indexed citations
5.
Klouche, Mariam, Andreas E. May, Martina Meßner, et al.. (1999). Enzymatically Modified, Nonoxidized LDL Induces Selective Adhesion and Transmigration of Monocytes and T-Lymphocytes Through Human Endothelial Cell Monolayers. Arteriosclerosis Thrombosis and Vascular Biology. 19(3). 784–793. 63 indexed citations
6.
Klouche, Mariam, Sandra Gottschling, Wolfgang Hell, et al.. (1998). Atherogenic Properties of Enzymatically Degraded LDL. Arteriosclerosis Thrombosis and Vascular Biology. 18(9). 1376–1385. 69 indexed citations
7.
Torzewski, Michael, Mariam Klouche, Martina Meßner, et al.. (1998). Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion. Arteriosclerosis Thrombosis and Vascular Biology. 18(3). 369–378. 151 indexed citations
8.
Meßner, Martina, Michael Pujari‐Palmer, Angela Valeva, et al.. (1996). Expression of Active Streptolysin O in Escherichia coli as a Maltose‐Binding‐Protein‐Streptolysin‐O Fusion Protein. European Journal of Biochemistry. 236(1). 34–39. 62 indexed citations
9.
Seifert, Paul S., et al.. (1991). Analysis of complement C3 activation products in human atherosclerotic lesions. Atherosclerosis. 91(1-2). 155–162. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Blandine Maître Breakdown of academic impact, for papers by BJ Rollins Breakdown of academic impact, for papers by Tadashi Onoda Breakdown of academic impact, for papers by Gunnel Östergren‐Lundén Breakdown of academic impact, for papers by Susanne Aschermann Breakdown of academic impact, for papers by Cam T. Ha Breakdown of academic impact, for papers by Keizo Kato Breakdown of academic impact, for papers by Selina McHarg Breakdown of academic impact, for papers by R. Standring Breakdown of academic impact, for papers by Katarzyna Grys
Rankless by CCL
2026